HR1986FEDERALin_committee

Proposed Spending Cap for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (H.R. 1986)

Original title: To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases for fiscal year 2024.

March 10, 2025

federal budget health care medical research appropriations

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the Subcommittee on Health.Apr 7, 2023

Lead sponsor

Andy Biggs

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This bill sets a hard ceiling on the federal budget for the National Institute of Arthritis and Musculoskeletal and Skin Diseases for fiscal year 2024, which dictates the maximum amount of funding available for research into skin, bone, and joint diseases.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

National Institute of Arthritis and Musculoskeletal and Skin Diseases

The agency's total available funding for fiscal year 2024 would be capped at $605,065,000.

Medical researchers and grant recipients

Funding availability for research projects overseen by NIAMS would be limited by the proposed budget cap.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes a federal spending limit of $605,065,000 for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for the 2024 fiscal year. If passed, this would override existing laws to cap the total funds available to the agency.

Key Facts

The bill establishes a maximum funding limit of $605,065,000 for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for fiscal year 2024.
This limitation applies notwithstanding any other provision of law.
The bill was introduced in the House of Representatives on March 29, 2023.
The bill has been referred to the House Committee on Energy and Commerce.

Why It Matters

Frequently Asked Questions

What does this bill do?

It sets a legal cap on the amount of money the National Institute of Arthritis and Musculoskeletal and Skin Diseases can receive for the 2024 fiscal year.

Does this bill cut funding?

The bill sets a maximum limit of $605,065,000; whether this constitutes a cut depends on the agency's current budget and requested appropriations for 2024.